March 6, 2006 Dear Health Care Professional, (OSI) Eyetech Inc. and Pfizer Inc. would like to inform you about important changes in the Macugen® (pegaptanib sodium injection) Prescribing Information concerning reports o - Eyetech - Document - PDFSEARCH.IO

First Page	Meta Content
	March 6, 2006 Dear Health Care Professional, (OSI) Eyetech Inc. and Pfizer Inc. would like to inform you about important changes in the Macugen® (pegaptanib sodium injection) Prescribing Information concerning reports o Add to Reading List Open Document File Size: 340,10 KB Share Result on Facebook Company Pfizer Inc. / MD Chief Scientific Officer (OSI) Eyetech Inc. / US Medical Pfizer Inc. / Eyetech Inc. / / Country United States / / / IndustryTerm Healthcare professionals / / MedicalCondition periocular infections / angioedema / hypersensitivity / macular degeneration / anaphylaxis / / Organization DOSAGE AND ADMINISTRATION / FDA / ADVERSE EVENTS and DOSAGE AND ADMINISTRATION / / Person Michael Widlitz / Anthony P. Adamis / / / Position General FOR OPHTHALMIC INTRAVITREAL INJECTION ONLY / Vice President / / Product Macugen / DOSAGE AND ADMINISTRATION The injection / OPHTHALMIC INTRAVITREAL INJECTION / / URL www.fda.gov/medwatch / / SocialTag Pfizer Type 1 hypersensitivity Ketorolac Anaphylaxis Package insert Intravitreal administration Medicine Health Pegaptanib

March 6, 2006 Dear Health Care Professional, (OSI) Eyetech Inc. and Pfizer Inc. would like to inform you about important changes in the Macugen® (pegaptanib sodium injection) Prescribing Information concerning reports oAdd to Reading List